Fluoxetine in Parkinson's disease

Mov Disord. 1996 Sep;11(5):581-2. doi: 10.1002/mds.870110517.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Cabergoline
  • Dopamine Agonists / therapeutic use
  • Double-Blind Method
  • Drug Therapy, Combination
  • Ergolines / therapeutic use
  • Female
  • Humans
  • Male
  • Middle Aged
  • Parkinson Disease / drug therapy*
  • Placebos
  • Selective Serotonin Reuptake Inhibitors / therapeutic use
  • Treatment Outcome

Substances

  • Dopamine Agonists
  • Ergolines
  • Placebos
  • Serotonin Uptake Inhibitors
  • Cabergoline